Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
AssigneeSun Pharma Advanced Research Company Ltd.
InventorsAjay Jaysingh KHOPADE, Arindam HALDER
Life of this patent
Estimating the term…
Loading patent…
AssigneeSun Pharma Advanced Research Company Ltd.
InventorsAjay Jaysingh KHOPADE, Arindam HALDER
Estimating the term…
The present invention relates to a method of increasing the bioavailability and/or prolonging ophthalmic action of a drug, the method comprising instilling into the eye an aqueous suspension comprising reversible clusters of drug loaded nano-resin particles, said clusters having a D50 value of at least 2 micrometer and said drug loaded nano-resin particles have a particle size distribution characterized in that the D90 value is 70 nanometer to 900 nanometer. The present invention further relates to an aqueous suspension comprising reversible clusters of drug loaded nano-resin particles, said clusters have a D50 value of at least 2 micrometers and said drug loaded nano-resin particles have a particle size distribution characterized in that the D90 value is 70 nanometers to 900 nanometers.
1-21. (canceled)
An aqueous suspension comprising reversible clusters of drug loaded ion-exchange resin particles, said clusters have a D50 value of at least 2 micrometers and the drug loaded ion-exchange resin particles have a particle size distribution characterized in that the D90 value is 70 to 900 nanometers, wherein the drug is brimonidine tartrate, and the brimonidine tartrate is present at a concentration of 0.35% w/v.
Dependencies are inferred from the claim text.